Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 3,356,500 | 3,131,100 | 3,307,001 | 3,077,800 | 3,078,400 |
| Cost of Goods | 421,000 | 446,000 | 509,200 | 370,000 | 366,200 |
| Gross Profit | 2,935,500 | 2,685,100 | 2,797,801 | 2,707,800 | 2,712,200 |
| Operating Expenses | 1,722,300 | 1,150,400 | 1,331,800 | 1,053,900 | 1,511,400 |
| Operating Income | 1,213,200 | 1,534,700 | 1,466,200 | 1,653,900 | 1,201,000 |
| Other Income | -34,500 | -41,000 | -66,400 | -44,000 | -68,600 |
| Pre-tax Income | 1,178,700 | 1,493,700 | 1,399,800 | 1,609,900 | 1,132,400 |
| Income Tax | 263,700 | 322,500 | 1,566,100 | 383,800 | 269,600 |
| Net Income Continuous | 915,000 | 1,171,200 | -166,300 | 1,226,100 | 862,800 |
| Minority Interests | 48,400 | -1,700 | 131,100 | N/A | N/A |
| Net Income | $866,600 | $1,172,900 | $-297,400 | $1,226,100 | $862,800 |
| EPS Basic Total Ops | 4.18 | 5.55 | -1.40 | 5.80 | 4.07 |
| EPS Basic Continuous Ops | 4.42 | 5.54 | -0.78 | 5.80 | 4.07 |
| EPS Diluted Total Ops | 4.18 | 5.54 | -1.40 | 5.79 | 4.07 |
| EPS Diluted Continuous Ops | 4.41 | 5.53 | -0.78 | 5.79 | 4.07 |
| EBITDA(a) | $1,384,700 | $1,703,600 | $1,675,201 | $1,831,300 | $1,383,600 |